Nuvelo Downgraded

Bank of America downgraded Nuvelo Inc. (NUVO) citing overly optimistic expectations that the company's failed blood clot treatment alfimeprase may be used to treat stroke patients. The stock price tumbled 97 cents to close at $4.43.